These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


198 related items for PubMed ID: 12825569

  • 1. Oseltamivir: new preparation. An antiviral agent with little impact on influenza.
    Prescrire Int; 2003 Jun; 12(65):85-8. PubMed ID: 12825569
    [Abstract] [Full Text] [Related]

  • 2. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antiviral treatment and prophylaxis of influenza in primary care: German recommendations.
    Wutzler P, Kossow KD, Lode H, Ruf BR, Scholz H, Vogel GE, Expert Group, German Association for the Control of Virus Diseases and Paul-Ehrlich Society of Germany.
    J Clin Virol; 2004 Oct; 31(2):84-91. PubMed ID: 15364262
    [Abstract] [Full Text] [Related]

  • 6. Zanamivir: new preparation. No tangible progress against influenza.
    Prescrire Int; 2000 Feb; 9(45):199-202. PubMed ID: 11503795
    [Abstract] [Full Text] [Related]

  • 7. Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza.
    Uyeki TM.
    Pediatr Infect Dis J; 2003 Feb; 22(2):164-77. PubMed ID: 12586981
    [Abstract] [Full Text] [Related]

  • 8. What is the best antiviral agent for influenza infection?
    Fagan HB, Moeller AH.
    Am Fam Physician; 2004 Oct 01; 70(7):1331-2. PubMed ID: 15508545
    [No Abstract] [Full Text] [Related]

  • 9. Experience with oseltamivir in the control of a nursing home influenza B outbreak.
    Parker R, Loewen N, Skowronski D.
    Can Commun Dis Rep; 2001 Mar 01; 27(5):37-40. PubMed ID: 11260987
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Neuraminidase inhibitors oseltamivir and zanamivir: new means of defence against influenza].
    de Jong JC, Beyer WE, Rimmelzwaan GF, Fouchier RA, Osterhaus AD.
    Ned Tijdschr Geneeskd; 2004 Jan 10; 148(2):73-9. PubMed ID: 14753128
    [Abstract] [Full Text] [Related]

  • 12. Zanamivir. No noticeable progress against influenza.
    Can Fam Physician; 2000 Oct 10; 46():2003-8, 2012-8. PubMed ID: 11184246
    [Abstract] [Full Text] [Related]

  • 13. Flu-fighting options: decisions, decisions...
    Rosen DS.
    Health News; 2000 Dec 10; 6(12):4. PubMed ID: 11142939
    [No Abstract] [Full Text] [Related]

  • 14. Antiviral therapy and prophylaxis for influenza in children.
    American Academy of Pediatrics Committee on Infectious Diseases.
    Pediatrics; 2007 Apr 10; 119(4):852-60. PubMed ID: 17403862
    [Abstract] [Full Text] [Related]

  • 15. Economic evaluation of oseltamivir phosphate for postexposure prophylaxis of influenza in long-term care facilities.
    Risebrough NA, Bowles SK, Simor AE, McGeer A, Oh PI.
    J Am Geriatr Soc; 2005 Mar 10; 53(3):444-51. PubMed ID: 15743287
    [Abstract] [Full Text] [Related]

  • 16. Neuraminidase inhibitors in the management of influenza--experience of an outpatient practice.
    Vogel GE.
    Med Microbiol Immunol; 2002 Dec 10; 191(3-4):161-3. PubMed ID: 12458352
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of zanamivir in patients with influenza--impact of age, severity of infections and specific risk factors.
    Höffken G, Gillissen A.
    Med Microbiol Immunol; 2002 Dec 10; 191(3-4):169-73. PubMed ID: 12458354
    [Abstract] [Full Text] [Related]

  • 18. Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season.
    Kawai N, Ikematsu H, Iwaki N, Satoh I, Kawashima T, Maeda T, Miyachi K, Hirotsu N, Shigematsu T, Kashiwagi S.
    Clin Infect Dis; 2005 May 01; 40(9):1309-16. PubMed ID: 15825034
    [Abstract] [Full Text] [Related]

  • 19. Use of Oseltamivir to control influenza complications after bone marrow transplantation.
    Machado CM, Boas LS, Mendes AV, da Rocha IF, Sturaro D, Dulley FL, Pannuti CS.
    Bone Marrow Transplant; 2004 Jul 01; 34(2):111-4. PubMed ID: 15094755
    [Abstract] [Full Text] [Related]

  • 20. Neuraminidase inhibitors slightly beneficial for shortening flu symptoms.
    Phillips TG.
    J Fam Pract; 2003 Oct 01; 52(10):747-8. PubMed ID: 14529590
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.